STOK · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2022-11-14 compared with 2022-08-08 · 2 added, 4 removed, 25 unchanged (19% of the section changed)
2 unchanged sentences
Filed/Furnished
−Removed: Scientific Advisory Board Agreement by and between Adrian Krainer, Ph.D.
−Removed: and the Registrant, dated June 1, 2022.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
STOKE THERAPEUTICS, INC.
−Removed: August 8, 2022
+Added: November 14, 2022
/s/ Edward M.
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 8, 2022
+Added: November 14, 2022
/s/ Stephen J.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.